Use of formulations for treating pathological vascular calcification occurring in renal disease, where the formulation contains trimagnesium dicitrate and/or trimagnesium diisocitrate as hydrate/anhydrate form

Use of formulations for treating pathological vascular calcification occurring in renal disease, where the formulation contains trimagnesium dicitrate and/or trimagnesium diisocitrate as hydrate/anhydrate form

Use of pharmaceutical formulations for the treatment of pathological vascular calcification occurring in renal disease, where the pharmaceutical formulation contains trimagnesium dicitrate and/or trimagnesium diisocitrate as an active agent, and the active agents are formed as a hydrate or anhydrate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: LIEDTKE, RAINER K
Format: Patent
Sprache:eng ; ger
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Use of pharmaceutical formulations for the treatment of pathological vascular calcification occurring in renal disease, where the pharmaceutical formulation contains trimagnesium dicitrate and/or trimagnesium diisocitrate as an active agent, and the active agents are formed as a hydrate or anhydrate, is claimed. ACTIVITY : Metabolic. MECHANISM OF ACTION : None given. Die Erfindung beschreibt die Verwendung pharmazeutischer Formulierungen von Trimagnesiumdicitrat und Trimagnesiumdiisocitrat Salzen zur Vorbeugung und Behandlung von Gefäßcalcifizierungen bei Nierenerkrankungen.